Netherlands· NL-e01df847a2b8

Lanreotide SUN 60 mg oplossing voor injectie in een voorgevulde spuit

A lanreotide product containing lanreotideacetaat, registered in Netherlands by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC H01CB03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lanreotideacetaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lanreotide is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CB03 (lanreotide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search lanreotide products by name

Lanreotide · ATC H01CB03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lanreotide costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lanreotide · price per daily dose (3 mg)

USD · FX 28 Sept 2026

FR France$53.80
CH Switzerland$44.46

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LANREOTIDEACETAAT
Manufacturer: Sun Pharmaceutical Industries Europe B.V.
Country: Netherlands (NL)
ATC code: H01CB03
ATC class: Lanreotide
Defined daily dose: 3 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
130727

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

157 interactions on record for lanreotide.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lanreotide against other medicines How interaction checks work

Lanreotide · interactions on record

157 records

2 severe
151 moderate
4 minor

Most severe, free to view

LonafarnibA16AX20severe
PexidartinibL01EX15severe
LiraglutidA08AX02moderate
SemaglutidA08AX03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lanreotide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lanreotide products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Lanreotid Sun Pharma, Lanreotid Viatris
Belgium · Lanreotide Sun, Lanreotide Viatris
Cyprus · Somatuline Autogel
Czechia · Lanreotid Sun, Lanreotid Zentiva
Germany · Lanreotid Sun, Lanreotid Viatris
Denmark · Ipstyl Autogel, Lanreotid Amdipharm Limited
Estonia · Myrelez, Somatuline Autogel
Spain · Lanreotida Sun, Lanreotida Zentiva
Finland · Lanreotid Sun, Lanreotid Zentiva
France · Lanreotide L.P. Biogaran, Lanréotide Viatris Lp
United Kingdom (Northern Ireland) · Lanreotide Mylan, Lanreotide Zentiva
Greece · Lanrod, Myrelez
Hungary · Lanreotid Sun, Somatuline Autogel
Ireland · Lanreotide Sun, Lanreotide Viatris
Italy · Ipstyl, Lanrenet
Lithuania · Myrelez, Somatuline Autogel
Luxembourg · Somatuline Autogel Injectable, Somatuline Autogel Injectable120
Latvia · Myrelez, Somatuline Autogel
Norway · Ipstyl Autogel, Lanreotid Sun
Poland · Lanreotide Zentiva, Myrelez
Portugal · Myrelez, Somatulina Autogel
Romania · Lanreotidă Terapia, Lanreotidă Zentiva
Sweden · Lanreotid Amdipharm, Lanreotid Sun
Slovenia · Somatuline Autogel
Slovakia · Lanreotid Sun, Lanreotid Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/2fc5410b-9758-4ad8-8e1f-d26c42f34138
GET /v1/drugs/2fc5410b-9758-4ad8-8e1f-d26c42f34138?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130727_smpc.pdf",
  "strength": null,
  "atc_label": "Lanreotide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130727",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "LANREOTIDEACETAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130727.pdf",
  "authorised_at": "2025/02/11",
  "procedure_number": "DE/H/7602/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130727",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about lanreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console